New York 2023-2024 Regular Session

New York Assembly Bill A00738

Introduced

1/11/23

Refer

1/11/23

Caption

Requires health insurance policies to cover comprehensive genetic screening and FDA approved biomarker testing for ovarian and prostate cancers.

Latest NY A00738 Activity

View All Events: NY 2023-2024 Regular Session A00738

Companion Bills

NY S00927

Same As Requires health insurance policies to cover comprehensive genetic screening and FDA approved biomarker testing for ovarian and prostate cancers.

Previously Filed As

NY S00927

Requires health insurance policies to cover comprehensive genetic screening and FDA approved biomarker testing for ovarian and prostate cancers.

NY A09075

Requires health insurance policies to cover comprehensive genetic screening and FDA approved biomarker testing for ovarian and prostate cancers.

NY A06475

Requires health insurance policies to cover comprehensive genetic screening and FDA approved biomarker testing for ovarian and prostate cancers.

NY HB2097

Health insurance; coverage requirements for prostate cancer screenings.

NY SB1314

Health insurance; coverage requirements for prostate cancer screenings.

NY HB477

Health insurance; coverage for prostate cancer screening.

NY SB00358

An Act Concerning Required Health Insurance Coverage For Breast And Ovarian Cancer Susceptibility Screening.

NY SB109

Health insurance; requiring coverage of certain genetic testing and cancer imaging; providing exclusions. Effective date.

NY HB830

Health Insurance - Genetic Testing and Cancer Imaging - Required Coverage

NY HB420

Insurance; require certain health benefit policies to cover genetic testing for an inherited mutation and cancer imaging under certain conditions

Similar Bills

No similar bills found.